Prevention of stroke: antiplatelet therapy.

Sethi, P.K. (2002) Prevention of stroke: antiplatelet therapy. Neurosciences Today, 6 (4). pp. 245-248.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
260 Kb

Abstract

Antiplatelet therapy is mainstay of secondary stroke prevention. It is recommended that every patient who has experienced a non cardioembolic stroke or TIA should receive an antiplatelet agent regularly to reduce the risk of recurrent stroke and other vascular events. Aspirin, or combination of aspirin with dipyridamole or clopidogrel are acceptable option or initial therapy. Fos patients who are allergic to aspirin, clopridogrel in favour of ticlopidine is recommended.

EPrint Type:Article
Uncontrolled Keywords:Antiplatelet Therapy, Stroke, Prevention, Aspirin, Dipyridamole Clopidogrel
Subjects:Cardiovascular Diseases > Vascular Diseases > Cerebrovascular Disorders
Hematologic, Gastrointestinal, and Renal Agents > Hematologic Agents > Platelet Aggregation Inhibitors
Nervous System Diseases > Trauma, Nervous System > Cerebrovascular Trauma
Cardiovascular Diseases > Vascular Diseases > Cerebrovascular Disorders > Cerebrovascular Accident
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrimidines
Organic Chemicals > Carboxylic Acids > Hydroxy Acids > Hydroxybenzoic Acids > Salicylic Acids
-Institutional Repositories > Sir Ganga Ram Hospital, New Delhi
ID Code:1755
Deposited By:Sir Ganga Ram Hospital
Deposited On:19 August 2006

Archive Staff Only: edit this record